Filing Details

Accession Number:
0000899243-18-026075
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-10-03 17:22:46
Reporting Period:
2018-10-01
Accepted Time:
2018-10-03 17:22:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1655759 Arvinas Inc. ARVN Pharmaceutical Preparations (2834) 472566120
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1753537 G John Houston C/O Arvinas, Inc.
5 Science Park, 395 Winchester Ave.
New Haven CT 06511
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-10-01 30,000 $16.00 772,860 No 4 P Direct
Common Stock Acquisiton 2018-10-01 12,484 $0.00 785,344 No 4 C Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 C Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series C Preferred Stock Disposition 2018-10-01 40,573 $0.00 12,484 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
Footnotes
  1. Reflects shares of the Issuer's Common Stock that were purchased in connection with the Issuer's initial public offering.
  2. On October 1, 2018, the Series C Preferred Stock converted into Common Stock on a 3.25-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.